ENFORCEMENT UPON FAILURE TO CURE. If the said noncompliance with the Quality Standards by Keysight or any Affiliate (as the case may be) remains uncured after the expiration of the Second Cure Period, then at Agilent’s election, Keysight or the non-complying Affiliate (as the case may be) promptly shall cease offering the non-complying Licensed Products under the Licensed Marks until Agilent reasonably determines that Keysight or the non-complying Affiliate (as the case may be) has reasonably demonstrated its ability and commitment to comply with the Quality Standards. Nothing in this Article VIII shall be deemed to limit Keysight’s obligations under Section 4.3 above or to preclude Agilent from exercising any rights or remedies under Section 4.3 above.
Appears in 5 contracts
Samples: Intellectual Property Matters Agreement (Keysight Technologies, Inc.), Trademark License Agreement (Keysight Technologies, Inc.), Intellectual Property Matters Agreement (Agilent Technologies Inc)
